NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Publication
, Journal Article
Abu-Rustum, NR; Yashar, CM; Arend, R; Barber, E; Bradley, K; Brooks, R; Campos, SM; Chino, J; Chon, HS; Crispens, MA; Damast, S; Fisher, CM ...
Published in: J Natl Compr Canc Netw
December 2023
The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2023
Volume
21
Issue
12
Start / End Page
1224 / 1233
Location
United States
Related Subject Headings
- Uterine Cervical Neoplasms
- Oncology & Carcinogenesis
- Humans
- Female
- Antineoplastic Combined Chemotherapy Protocols
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Abu-Rustum, N. R., Yashar, C. M., Arend, R., Barber, E., Bradley, K., Brooks, R., … Espinosa, S. (2023). NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw, 21(12), 1224–1233. https://doi.org/10.6004/jnccn.2023.0062
Abu-Rustum, Nadeem R., Catheryn M. Yashar, Rebecca Arend, Emma Barber, Kristin Bradley, Rebecca Brooks, Susana M. Campos, et al. “NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.” J Natl Compr Canc Netw 21, no. 12 (December 2023): 1224–33. https://doi.org/10.6004/jnccn.2023.0062.
Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw. 2023 Dec;21(12):1224–33.
Abu-Rustum, Nadeem R., et al. “NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.” J Natl Compr Canc Netw, vol. 21, no. 12, Dec. 2023, pp. 1224–33. Pubmed, doi:10.6004/jnccn.2023.0062.
Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw. 2023 Dec;21(12):1224–1233.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2023
Volume
21
Issue
12
Start / End Page
1224 / 1233
Location
United States
Related Subject Headings
- Uterine Cervical Neoplasms
- Oncology & Carcinogenesis
- Humans
- Female
- Antineoplastic Combined Chemotherapy Protocols
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis